Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
about
Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitorThe carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivoNew insights into the biology of tissue factor pathway inhibitorSmall Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor VIIa by Tissue Factor Pathway Inhibitor (TFPI)Biology of tissue factor pathway inhibitor.Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitorVascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque developmentC-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules.The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibitionEndothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis.Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.Quantification of heparin-induced TFPI release: a maximum release at low heparin dose.Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use.The C-terminus of tissue factor pathway inhibitor α is required for its interaction with factors V and VaComplementary DNA sequencing of canine tissue factor pathway inhibitor reveals a unique nanomeric repetitive sequence between the second and third Kunitz domains.Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβLow plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor.Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo.Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice.Alternatively spliced isoforms of tissue factor pathway inhibitorAlternatively spliced tissue factor pathway inhibitor: functional implications.Tissue factor pathway inhibitor: structure-function.TFPI cofactor function of protein S: essential role of the protein S SHBG-like domainFactor V has an anticoagulant cofactor activity that targets the early phase of coagulation.Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.Oxidized low-density lipoprotein impairs the anti-coagulant function of tissue-factor-pathway inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells.Gla-domainless factor Xa: molecular bait to bypass a blocked tenase complex.Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor.Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.An ecoimmunological approach to study evolutionary and ancient links between coagulation, complement and Innate immunity.
P2860
Q24563581-576B7B07-19FC-4704-9A1B-4A9F969E513CQ24630259-11F664C0-7F0F-4C59-975F-38839B597CCDQ26865048-99E673F5-8A26-40B3-97B5-202AF1D3431EQ27680684-74EE578F-0CB9-4DA8-81EB-0CCB75736785Q33585249-1996E26A-648D-4CEF-9D95-F10CDB1F43A0Q33648222-47190C13-9F02-4696-B166-C29133C838E4Q33779431-33A30F80-D2FF-403D-A950-CD6C9C1E14DCQ34107512-457F4461-97DC-43B5-836B-EDE1C9BB2B8EQ34122695-B8E7C954-B21A-4FD0-8ACD-94ABEEE8AD51Q34163034-83858089-B88C-4B87-AC7B-05739C1F04FEQ34479961-AB694779-F29F-4948-B3A7-1E744CDF1CFFQ35804173-E86EF31C-029E-4BF2-971F-10D38E74B52CQ36269547-FD9BBBCA-F372-41CC-AE5B-3AE810A449D9Q36290613-B5F02CE0-9D87-4F5E-8E08-4C2387A04A1DQ36728845-FCB7AE53-2CE8-401C-A3EF-900043B85841Q36852177-860FFB7C-D3FD-4A61-B0EE-62E80E2FE634Q36948563-2CFC6B14-2C3B-4E1F-B7E4-E15E6A961777Q37268966-55717735-E8C1-493B-AF3C-35049207EE36Q37390247-8A3214D3-E88A-489C-9EFB-C7097F5D6E73Q37418452-26DFAE0B-46F3-4B58-8A4E-41591FC83E9BQ37696775-4E061AEE-66D8-4471-A77F-FBA65F8B1021Q37881747-2B45CE91-DE6E-4859-8B36-4AE946AB50F0Q37971520-B62F3202-DE9F-4947-B564-12BFBB98323FQ40915457-447A46C3-22CF-4D83-8E93-DA65D8160168Q41936652-988F76E4-C3DB-4973-97C6-CF22285F3081Q41982133-4A9633B1-8460-485B-8840-56B40BFA557FQ42158171-C4388854-82F5-4467-92E7-8DD3AD983C48Q42257925-BD0BEFD0-1F88-4E2C-A059-5ED7EE9F7B02Q42832371-AA58F45A-40C8-43C9-B1F6-5A8403490449Q43002265-5667A9A9-897D-49B0-AF88-A92FB227DD23Q54267933-207DEAB3-DCE7-48B0-A11E-62C09CF5D10D
P2860
Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Tissue factor pathway inhibito ...... timal inhibition of factor Xa.
@en
type
label
Tissue factor pathway inhibito ...... timal inhibition of factor Xa.
@en
prefLabel
Tissue factor pathway inhibito ...... timal inhibition of factor Xa.
@en
P2093
P1433
P1476
Tissue factor pathway inhibito ...... ptimal inhibition of factor Xa
@en
P2093
P304
P407
P577
1992-04-01T00:00:00Z